Shanghai Junshi Biosciences Co Ltd
SEHK:1877
China / Healthcare / Biotechnology
Exchange Data
Hide this widget
Price
15.38 HKD
Day change
0.74 (5.05%)
52-week range
9.17 - 21.70
07:59 - Closed
Summary of Shanghai Junshi Biosciences Co Ltd
Hide this widget
Shanghai Junshi Biosciences Co., Ltd., a biopharmaceutical company, engages in the discovery, development, and commercialization of various drugs in t...
Price History
Chart Gallery
Hide this widget
1 Week
1 Month
3 Months
1 Year
5 Year
10 Years
- (-)
Data Explorer
Hide this widget
Data could not be retrieved
Peer Benchmarks
Hide this widget
Quote
Value
Size
Growth
Profit
| 1877 | Peers | Sector | |
|---|---|---|---|
Market Cap | 28.168 B | 3.358 B | 499.5 M |
Price % of 52 Week High | Premium | 72.3% | 62.0% |
Dividend Yield | 0.0% | 0.0% | 0.0% |
Shareholder Yield | Premium | 0.1% | -0.7% |
1 Year Price Total Return | 55.8% | 22.5% | -12.0% |
Beta (5 Year) | - | 0.62 | 0.64 |
In the News
Hide this widget
Fair Value
Hide this widget
Average
–
Upside
–
Uncertainty
–
Spread
–
Financial Health
Health Details
Hide this widget
Financial Health for Shanghai Junshi Biosciences is determined by ranking the company on over 100 factors against companies in the Healthcare sector and operating in Developing economic markets.
12345
Financial Models for Shanghai Junshi Biosciences Co Ltd
Model Gallery
Hide this widget
| 10Y DCF EBITDA ExitView Updated 8 hours ago |
| 10Y DCF Revenue ExitView Updated 8 hours ago |
| 10Y DCF Growth ExitView Updated 8 hours ago |
| 5Y DCF EBITDA ExitView Updated 8 hours ago |
| 5Y DCF Revenue ExitView Updated 8 hours ago |
| 5Y DCF Growth ExitView Updated 8 hours ago |
| DuPont ROE AnalysisView Updated 7 hours ago |
| 10Y Historical FinancialsView Updated 7 hours ago |
| 5Y Historical FinancialsView Updated 7 hours ago |
| EV / EBIT MultiplesView Updated 8 hours ago |
| EV / EBITDA MultiplesView Updated 8 hours ago |
| P/E MultiplesView Updated 8 hours ago |
| Price / Book MultiplesView Updated 8 hours ago |
| Price / Sales MultiplesView Updated 8 hours ago |
| EV / Revenue MultiplesView Updated 8 hours ago |
| CAPM WACC ModelView Updated 7 hours ago |
| Earnings Power ValueView Updated 8 hours ago |
Historical Financials
Full Financials
Hide this widget
| (HKD in millions) | Trailing Twelve Months | Fiscal Quarters | |||
|---|---|---|---|---|---|
| Period Ending | Dec-22 | Dec-23 | Dec-24 | Dec-23 | Dec-24 |
| Income Statement | |||||
| Revenue | 1,645 | 1,653 | 2,073 | 568 | 721 |
| Operating Income | InvPro+ | InvPro+ | InvPro+ | InvPro+ | InvPro+ |
| Net Profit | InvPro+ | InvPro+ | InvPro+ | InvPro+ | InvPro+ |
| Diluted EPS | InvPro+ | InvPro+ | InvPro+ | InvPro+ | InvPro+ |
| EBITDA | |||||
| Balance Sheet | |||||
| Cash & ST Invest. | InvPro+ | InvPro+ | InvPro+ | InvPro+ | InvPro+ |
| Current Assets | InvPro+ | InvPro+ | InvPro+ | InvPro+ | InvPro+ |
| Total Assets | InvPro+ | InvPro+ | InvPro+ | InvPro+ | InvPro+ |
| Current Liabilities | InvPro+ | InvPro+ | InvPro+ | InvPro+ | InvPro+ |
| Total Liabilities | InvPro+ | InvPro+ | InvPro+ | InvPro+ | InvPro+ |
| Total Equity | InvPro+ | InvPro+ | InvPro+ | InvPro+ | InvPro+ |
| Total Debt | 1,496 | 1,968 | 3,119 | 1,968 | 3,119 |
| Cash Flow Statement | |||||
| Cash Flow Operations | InvPro+ | InvPro+ | InvPro+ | InvPro+ | InvPro+ |
| Cash From Investing | InvPro+ | InvPro+ | InvPro+ | InvPro+ | InvPro+ |
| Cash From Financing | InvPro+ | InvPro+ | InvPro+ | InvPro+ | InvPro+ |
| Free Cash Flow | (2,456) | (3,122) | (2,261) | (626) | (416) |
Analyst Notes
March 29, 2025
Hide this widget